Extended Data Fig. 9: The therapeutic effect of EG00229 on pulmonary fibrosis is dependent on lung ILC2s. | Nature Immunology

Extended Data Fig. 9: The therapeutic effect of EG00229 on pulmonary fibrosis is dependent on lung ILC2s.

From: Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity

Extended Data Fig. 9

(a) Bleomycin-challenged Rag1/ mice were treated with EG00229 (10 mg/kg body weight) or DMSO control intraperitoneally for three weeks. Each group of mice were also received 200 μg of anti-Thy1.2 or isotype control antibodies every 3 days throughout the treatment. Masson’s trichrome staining for each group was shown. Data are representative of 3 independent experiments.

Back to article page